Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.81
+0.88 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edwards Lifesciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 4,159 | 1,402 | 1,522 | 1,503 | 823.4 | 1,047 | Upgrade
|
Depreciation & Amortization | 149.3 | 144.9 | 139.6 | 134.8 | 107.2 | 89.3 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 55.1 | 4 | - | 64.6 | Upgrade
|
Loss (Gain) From Sale of Investments | 0.1 | 0.1 | 51.5 | -36.8 | -21.2 | - | Upgrade
|
Stock-Based Compensation | 161.1 | 139.4 | 126.8 | 109.3 | 92.6 | 81.3 | Upgrade
|
Other Operating Activities | -313.3 | -264.7 | -255.3 | -127.6 | 10.1 | 101.6 | Upgrade
|
Change in Accounts Receivable | -2.9 | -141.2 | -84.1 | -91.1 | 41.9 | -88 | Upgrade
|
Change in Inventory | -304.2 | -289 | -213.4 | 19 | -120.6 | -105.4 | Upgrade
|
Change in Accounts Payable | 126 | 146 | -21.4 | 195.2 | -84.5 | 116.5 | Upgrade
|
Change in Income Taxes | 189.7 | -5.8 | -5.6 | 62 | -52.9 | 43.2 | Upgrade
|
Change in Other Net Operating Assets | -20.9 | -236.3 | -96.9 | -39.8 | 258.3 | -167.1 | Upgrade
|
Operating Cash Flow | 806.4 | 895.8 | 1,218 | 1,732 | 1,054 | 1,183 | Upgrade
|
Operating Cash Flow Growth | -22.61% | -26.47% | -29.67% | 64.29% | -10.87% | 27.65% | Upgrade
|
Capital Expenditures | -290.9 | -253 | -244.6 | -325.8 | -407 | -254.4 | Upgrade
|
Cash Acquisitions | -717.6 | -95.2 | - | - | - | -100.2 | Upgrade
|
Sale (Purchase) of Intangibles | -25.4 | -13.3 | -20.2 | -4 | -0.3 | -24 | Upgrade
|
Investment in Securities | 128.2 | 640.3 | 689.8 | -1,350 | -74.7 | -158.2 | Upgrade
|
Other Investing Activities | -118 | -105 | -172.7 | -42.6 | -49.1 | -59 | Upgrade
|
Investing Cash Flow | 2,904 | 173.8 | 252.3 | -1,723 | -531.1 | -595.8 | Upgrade
|
Long-Term Debt Issued | - | - | - | 5.2 | 16.2 | 18.9 | Upgrade
|
Long-Term Debt Repaid | - | -0.3 | -0.2 | -7 | -17 | -28.9 | Upgrade
|
Net Debt Issued (Repaid) | -0.3 | -0.3 | -0.2 | -1.8 | -0.8 | -10 | Upgrade
|
Issuance of Common Stock | 184.1 | 169.9 | 146.4 | 158.6 | 140.5 | 160.5 | Upgrade
|
Repurchase of Common Stock | -1,608 | -879.6 | -1,727 | -512.8 | -625.4 | -263.3 | Upgrade
|
Other Financing Activities | -0.9 | -1 | -3.6 | -0.3 | -1.2 | -2.8 | Upgrade
|
Financing Cash Flow | -1,425 | -711 | -1,585 | -356.3 | -486.9 | -115.6 | Upgrade
|
Foreign Exchange Rate Adjustments | -15.8 | 16.8 | 19.2 | 13.9 | -20.5 | -3 | Upgrade
|
Net Cash Flow | 2,270 | 375.4 | -94.8 | -332.8 | 15.8 | 468.5 | Upgrade
|
Free Cash Flow | 515.5 | 642.8 | 973.6 | 1,406 | 647.3 | 928.5 | Upgrade
|
Free Cash Flow Growth | -36.23% | -33.98% | -30.77% | 117.26% | -30.29% | 34.96% | Upgrade
|
Free Cash Flow Margin | 8.16% | 10.70% | 18.09% | 26.88% | 14.76% | 21.35% | Upgrade
|
Free Cash Flow Per Share | 0.85 | 1.05 | 1.56 | 2.23 | 1.02 | 1.46 | Upgrade
|
Cash Interest Paid | 19.9 | 19.9 | 19.3 | 20.2 | 19.9 | 19.9 | Upgrade
|
Cash Income Tax Paid | 877.8 | 470.1 | 504.1 | 182.5 | 197.9 | 61.5 | Upgrade
|
Levered Free Cash Flow | 1,792 | 751.03 | 933.04 | 1,009 | 373.75 | 516.93 | Upgrade
|
Unlevered Free Cash Flow | 1,803 | 762.03 | 945.04 | 1,020 | 383.63 | 529.86 | Upgrade
|
Change in Net Working Capital | -627.3 | 337.1 | 176.5 | -114.6 | 231.5 | 136.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.